
Sign up to save your podcasts
Or


There's still lots to learn about omicron, but two things are certain: vaccinations will provide some level of protection, and until the majority of the world's population is vaccinated, we may continue to see new variants. Vaccine experts Dr. Anna Durbin and Dr. Bill Moss talk with Stephanie Desmon about viral mutations and what we might expect to see when it comes to SARS-CoV-2, what needs to be done to address ongoing challenges with global vaccine distribution, and the importance of sharing vaccine technology to help curb future pandemics.
By The Johns Hopkins Bloomberg School of Public Health4.6
618618 ratings
There's still lots to learn about omicron, but two things are certain: vaccinations will provide some level of protection, and until the majority of the world's population is vaccinated, we may continue to see new variants. Vaccine experts Dr. Anna Durbin and Dr. Bill Moss talk with Stephanie Desmon about viral mutations and what we might expect to see when it comes to SARS-CoV-2, what needs to be done to address ongoing challenges with global vaccine distribution, and the importance of sharing vaccine technology to help curb future pandemics.

43,700 Listeners

40 Listeners

5 Listeners

26 Listeners

5 Listeners

263 Listeners

56,902 Listeners

495 Listeners

9 Listeners

45 Listeners

91 Listeners

16,386 Listeners

16 Listeners

4,825 Listeners

2 Listeners

4,482 Listeners

389 Listeners

6,568 Listeners

25 Listeners

6,453 Listeners

231 Listeners

66 Listeners

167 Listeners

111 Listeners